| Lindsay Nicole French-rosas, MD | |
|
303 Bryant St, Mountain View, CA 94041-1552 | |
| (888) 995-2230 | |
| (650) 242-7520 |
| Full Name | Lindsay Nicole French-rosas |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 303 Bryant St, Mountain View, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407011018 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | BP10030740 (Texas) | Primary |
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.
This Memorial Day weekend at the 2011 Annual ACA Meeting, Bruker will launch a new series of high-performance X-ray crystallography systems, including the D8 QUEST and the D8 VENTURE.
Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.
Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
› Verified 5 days ago
| Entity Name | Border Region Mh Mr Community Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124060173 PECOS PAC ID: 0648207381 Enrollment ID: O20061026000464 |
News Archive
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.
This Memorial Day weekend at the 2011 Annual ACA Meeting, Bruker will launch a new series of high-performance X-ray crystallography systems, including the D8 QUEST and the D8 VENTURE.
Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.
Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
› Verified 5 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.
This Memorial Day weekend at the 2011 Annual ACA Meeting, Bruker will launch a new series of high-performance X-ray crystallography systems, including the D8 QUEST and the D8 VENTURE.
Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.
Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Nicole French-rosas, MD 303 Bryant St, Mountain View, CA 94041-1552 Ph: (888) 995-2230 | Lindsay Nicole French-rosas, MD 303 Bryant St, Mountain View, CA 94041-1552 Ph: (888) 995-2230 |
News Archive
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy.
This Memorial Day weekend at the 2011 Annual ACA Meeting, Bruker will launch a new series of high-performance X-ray crystallography systems, including the D8 QUEST and the D8 VENTURE.
Hotspur Technologies, Inc. announced today that Dr. Bruce Lin, M.D., and Dr. Stephen Liu, M.D., Interventional Radiologists at Lifelink Interventional Center in Modesto, California, performed the first commercial deployment of the company's GPSCath™ Balloon Dilatation Catheter.
Noven Pharmaceuticals, Inc. today confirmed that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market its rivastigmine transdermal system in 4.6 mg/24 hours and 9.5 mg/24 hours dosage strengths.
Targeted Genetics Corporation announced today that its licensing partner, Celladon Corporation, has reported today that Celladon's first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.
› Verified 5 days ago
John Earle Barnes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7300 | |
Katie Cheng, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 303 Bryant St, Mountain View, CA 94041 Phone: 888-995-2230 Fax: 650-242-7520 | |
Ariele Greenfield, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7300 | |
Dr. Stanley Edwin Fischman, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2485 Hospital Dr, Suite 351, Mountain View, CA 94040 Phone: 650-988-7676 Fax: 650-988-7674 | |
Dr. Anton Ostashko, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2500 Hospital Dr Ste 4b, Mountain View, CA 94040 Phone: 650-492-7999 Fax: 650-305-7999 | |
Zahida Sarwar Tayyib, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Dr Ste 3a, Mountain View, CA 94040 Phone: 650-969-6772 Fax: 650-969-6772 | |
Dr. Anita Josefa Barzman, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2685 Marine Way, #1220, Mountain View, CA 94043 Phone: 650-938-1865 |